Last reviewed · How we verify
Albiglutide Lyophilized DCC Pen Injector
Albiglutide Lyophilized DCC Pen Injector is a GLP-1 receptor agonist Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 1 development for Type 2 diabetes.
GLP-1 receptor agonist
GLP-1 receptor agonist Used for Type 2 diabetes.
At a glance
| Generic name | Albiglutide Lyophilized DCC Pen Injector |
|---|---|
| Sponsor | GlaxoSmithKline |
| Drug class | GLP-1 receptor agonist |
| Target | GLP-1R |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 1 |
Mechanism of action
Albiglutide is a long-acting GLP-1 receptor agonist that mimics the action of the incretin hormone glucagon-like peptide-1 (GLP-1) to regulate glucose metabolism.
Approved indications
- Type 2 diabetes
Common side effects
- Nausea
- Vomiting
- Diarrhea
Key clinical trials
- Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus (PHASE3)
- A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus (PHASE3)
- Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Albiglutide Lyophilized DCC Pen Injector CI brief — competitive landscape report
- Albiglutide Lyophilized DCC Pen Injector updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Albiglutide Lyophilized DCC Pen Injector
What is Albiglutide Lyophilized DCC Pen Injector?
How does Albiglutide Lyophilized DCC Pen Injector work?
What is Albiglutide Lyophilized DCC Pen Injector used for?
Who makes Albiglutide Lyophilized DCC Pen Injector?
What drug class is Albiglutide Lyophilized DCC Pen Injector in?
What development phase is Albiglutide Lyophilized DCC Pen Injector in?
What are the side effects of Albiglutide Lyophilized DCC Pen Injector?
What does Albiglutide Lyophilized DCC Pen Injector target?
Related
- Drug class: All GLP-1 receptor agonist drugs
- Target: All drugs targeting GLP-1R
- Manufacturer: GlaxoSmithKline — full pipeline
- Therapeutic area: All drugs in Diabetes
- Indication: Drugs for Type 2 diabetes
- Compare: Albiglutide Lyophilized DCC Pen Injector vs similar drugs
- Pricing: Albiglutide Lyophilized DCC Pen Injector cost, discount & access